home / stock / lxxgf / lxxgf news

LXXGF News and Press, Lexagene Holdings

Stock Information
Company Name: Lexagene Holdings
Stock Symbol: LXXGF
Market: OTC
Website: lexagene.com
Menu
LXXGF LXXGF Quote LXXGF Short LXXGF News LXXGF Articles LXXGF Message Board
Get LXXGF Alerts

News, Short Squeeze, Breakout and More Instantly...
LXXGF - LexaGene Holdings files for bankruptcy

LexaGene Holdings ( OTCQB:LXXGF ) has filed a voluntary petition for relief under Chapter 7 of the U.S. Bankruptcy Code. The molecular diagnostics company said it has ceased operations and laid off its staff. A U.S. court is set to appoint a bankruptcy trustee to liquidate t...
LXXGF - LexaGene Files for Chapter 7 Bankruptcy

BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...

LXXGF - LexaGene Holdings Announces Results of February 8, 2023 Annual General Meeting

BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...

LXXGF - LexaGene Provides Update on BioPharma Sector

BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...
LXXGF - LexaGene's MiQLab System Detects Mycoplasma at Minute Levels, Rousing Additional Interest from BioPharma Customers

BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab TM System for autom...

LXXGF - BioPharma Engages LexaGene in Second Feasibility Study

BEVERLY, Mass. , Dec. 16, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, ge...

LXXGF - LexaGene Successfully Completes Statement of Work for BioPharma Company

BEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automate...
LXXGF - LexaGene Closes Secured Convertible Note Transaction

BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...

LXXGF - LexaGene Holdings Proposes to Amend Warrants Terms

BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...

LXXGF - LexaGene enters into secured convertible note agreement

Molecular diagnostics company LexaGene ( OTCQB:LXXGF ) has entered secured convertible note agreement with Meridian LGH, an affiliate of an insider of the company, in the aggregate principal amount of up to $1.6M. The note bears interest at 12% per annum and matures on Ma...
Next 10